Genetic Technologies
GENE
#10485
Rank
A$5.58 M
Marketcap
A$1.15
Share price
0.00%
Change (1 day)
-69.78%
Change (1 year)

Genetic Technologies (GENE) - Total debt

Total debt on the balance sheet as of June 2024 : A$0.88 Million

According to Genetic Technologies's latest financial reports the company's total debt is A$0.88 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Genetic Technologies - Total debt on balance sheet (from 2004 to 2024)

Total debt by year

Year Total debt Change
2024-06-30A$0.87 M64.25%
2023-06-30A$0.53 M-18.34%
2022-06-30A$0.65 M219.81%
2021-06-30A$0.2 M-57.65%
2020-06-30A$0.48 M
2019-06-30N/A
2015-06-30A$0.02 M-99%
2014-06-30A$2.5 M
2013-06-30N/A-100%
2012-06-30A$0.01 M-73.85%
2011-06-30A$0.06 M-82.26%
2010-06-30A$0.38 M2.46%
2009-06-30A$0.37 M25.23%
2008-06-30A$0.29 M-43.08%
2007-06-30A$0.52 M-68.87%
2006-06-30A$1.68 M-17.58%
2005-06-30A$2.04 M193.31%
2004-06-30A$0.69 M-0.11%
2003-06-30A$0.69 M
2002-06-30N/A-100%
2001-06-30A$0.12 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
A$0.83 M-5.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
A$0.31 B 36,143.27%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$9.83 B 1,114,666.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$9.61 B 1,089,417.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
A$4.43 M 402.93%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
A$25.38 B 2,877,509.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$53.73 B 6,091,090.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
A$1.19 B 135,198.52%๐Ÿ‡บ๐Ÿ‡ธ USA